Offer - Urjas Oil for just ₹ 1 X
Alphalan 5 Tablet is a commercial drug that is prescribed in the form of Tablet. Multiple Myeloma are some of its major therapeutic uses. Other than this, Alphalan 5 Tablet has some other therapeutic uses, which have been discussed ahead.
The optimal dosage of Alphalan 5 Tablet is largely dependent on the individual's body weight, medical history, gender and age. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. This information has been provided in detail in the dosage section.
While these are the most often observed Alphalan 5 Tablet side effects, there are can be others also. These have been listed below. Usually, these side effects of Alphalan 5 Tablet go away soon, and do not persist beyond the duration of the treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
Furthermore, you should know that effect of Alphalan 5 Tablet is Severe for pregnant women and Severe for women who are breastfeeding. Warnings related to Alphalan 5 Tablet's effects on the liver, heart and kidney, if any, have been listed below.
Other conditions have been mentioned below in the Alphalan 5 Tablet contraindications section.
Drug reaction of Alphalan 5 Tablet with other medicines has been reported. A complete list of these interactions is given below.
You should also be aware that Alphalan 5 Tablet is not safe while driving, and is not addiction.
Alphalan 5 Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Adult(Female) |
|
Geriatric |
|
Is the use of Alphalan 5 Tablet safe for pregnant women?
Alphalan has many dangerous side effects in pregnant women. If you are pregnant, do not consume Alphalan without medical advice.
Is the use of Alphalan 5 Tablet safe during breastfeeding?
Women who are breastfeeding, may experience serious side effects after taking Alphalan. So it is adviced to consult the doctor before using it.
What is the effect of Alphalan 5 Tablet on the Kidneys?
Alphalan has very mild side effects on the kidneys.
What is the effect of Alphalan 5 Tablet on the Liver?
Alphalan has very mild side effects on the liver.
What is the effect of Alphalan 5 Tablet on the Heart?
Alphalan has very mild side effects on the heart.
Alphalan 5 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Alphalan 5 Tablet unless your doctor advises you to do so -
Is this Alphalan 5 Tablet habit forming or addictive?
No, there is no any evidence that Alphalan 5 Tablet is addictive.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Alphalan 5 Tablet. So it is best to avoid driving.
Is it safe?
Alphalan 5 Tablet should be used only after doctor's advice.
Is it able to treat mental disorders?
There is no benefit of taking Alphalan 5 Tablet for mental disorders.
Interaction between Food and Alphalan 5 Tablet
You can take Alphalan 5 Tablet with food.
Interaction between Alcohol and Alphalan 5 Tablet
Information about the interaction of Alphalan 5 Tablet and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Evomela (melphalan)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 861
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 810-812